Welcome to LookChem.com Sign In|Join Free
  • or
4-(2-THENOYL)PYRIDINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

21314-80-7

Post Buying Request

21314-80-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

21314-80-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 21314-80-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,3,1 and 4 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 21314-80:
(7*2)+(6*1)+(5*3)+(4*1)+(3*4)+(2*8)+(1*0)=67
67 % 10 = 7
So 21314-80-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H7NOS/c12-10(9-2-1-7-13-9)8-3-5-11-6-4-8/h1-7H

21314-80-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(2-THENOYL)PYRIDINE

1.2 Other means of identification

Product number -
Other names 2-Thienyl-4'-pyridyl ketone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21314-80-7 SDS

21314-80-7Downstream Products

21314-80-7Relevant academic research and scientific papers

Imidazolines as efficacious glucose-dependent stimulators of insulin secretion

Jakobsen, Palle,Madsen, Peter,Andersen, HenrikSune

, p. 357 - 362 (2003)

Synthesis of a series of imidazolines with glucose dependent effects on insulin exocytosis from pancreatic β-cells is reported. Regioisomers and enantiomers were found to exhibit marked differences in exocytotic effects as well as different activities on the KATP-channel; the (R (+)) isomer of 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-thiophene-2-ylethyl]pyridin e (4a) and the (+) isomer of 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-thiophene-3-ylethyl]pyridin e (4d) were found to give a significant increase in insulin release - in contrast to findings for their enantiomers - without influence on the KATP-channel. The (+) isomer (4a) showed glucose dependent insulin release from β-cells at concentrations above 2.5 mM and a marked glucose lowering effect in ob/ob mice as well as in fed but not in fasted rats.

Oral hypoglycaemic agents

-

, (2008/06/13)

Compounds of formula (I) which are optionally substituted 2-(ω,ω-diarylalkyl)-4,5-dihydro-1H-imidazoles and 2-(ω,ω-diarylalkyl)-1,4,5,6-tetrahydropyrimidines and salts thereof with inorganic and organic acids have interesting pharmacological properties. T

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 21314-80-7